Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: A randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 314, Issue 18, 2015, Pages 1936-1944

  Fakhry, Farzin ^a   Spronk, Sandra ^b   Van Der Laan, Lijckle ^c   Wever, Jan J ^d   Teijink, Joep A W ^e   Hoffmann, Wolter H ^f   Smits, Taco M ^g   Van Brussel, Jerome P ^h   Stultiens, Guido N M ⁱ   Derom, Alex ^j   Den Hoed, P Ted ^k   Ho, Gwan H ^c   Van Dijk, Lukas C ^d   Verhofstad, Nicole ^e   Orsini, Mariella ^f   Van Petersen, Andre ^g   Woltman, Kristel ^h   Hulst, Ingrid ^d   Van Sambeek, Marc R H M ^e   Rizopoulos, Dimitris ^a   Rouwet, Ellen V ^a   Hunink, M G Myriam ^a,l   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Welfare and Sport   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

^d HAGA HOSPITAL   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

^f REINIER DE GRAAF HOSPITAL   (Netherlands)

^g BERNHOVEN HOSPITAL   (Netherlands)

^h SINT FRANCISCUS GASTHUIS   (Netherlands)

ⁱ ELKERLIEK HOSPITAL   (Netherlands)

^j ZorgSaam Hospital   (Netherlands)

^k IKAZIA HOSPITAL   (Netherlands)

^l HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALGESIA; ARTERY DISSECTION; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; ENDARTERECTOMY; FEMALE; FOLLOW UP; GROIN HEMATOMA; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NETHERLANDS; PERCUTANEOUS THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SHORT FORM 36; TREADMILL TEST; TREATMENT OUTCOME; VASCULAR QUALITY OF LIFE SCORE; VASCULAR STENT; WALKING; CLINICAL TRIAL; HEALTH STATUS; MULTIMODALITY CANCER THERAPY; PERIPHERAL ARTERIAL DISEASE; PROCEDURES; QUALITY OF LIFE; VASCULAR SURGERY;

AGED; COMBINED MODALITY THERAPY; EXERCISE THERAPY; FEMALE; HEALTH STATUS; HUMANS; INTENTION TO TREAT ANALYSIS; INTERMITTENT CLAUDICATION; MALE; PERIPHERAL ARTERIAL DISEASE; QUALITY OF LIFE; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES; WALKING;

EID: 84946719622     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.14851     Document Type: Article

References (39)

1. Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010. Lancet. 2013;382(9901):1329-1340.
2. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004;292(4):453-461.
3. Sieminski DJ, Gardner AW. The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease. Vasc Med. 1997;2(4):286-291.
4. Khaira HS, Hanger R, Shearman CP. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 1996;11(1):65-69.
5. Fakhry F, van de Luijtgaarden KM, Bax L, et al. Supervised walking therapy in patients with intermittent claudication. J Vasc Surg. 2012;56(4): 1132-1142.
6. TenderaM, Aboyans V, BartelinkML, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J. 2011;32(22): 2851-2906.
7. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal,mesenteric, and abdominal aortic). Circulation. 2006;113(11):e463-e654.
8. 2011Writing Group Members; 2005Writing Committee Members; ACCF/AHA Task Force Members. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). Circulation. 2011;124(18):2020-2045.
9. Norgren L, HiattWR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5-S67.
10. Makris GC, Lattimer CR, Lavida A, Geroulakos G. Availability of supervised exercise programs and the role of structured home-based exercise in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2012;44(6):569-575.
11. Beckman JA. Peripheral endovascular revascularization: some proof in the pudding? Circulation. 2007;115(5):550-552.
12. Frans FA, Bipat S, Reekers JA, et al. Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication. Br J Surg. 2012;99(1):16-28.
13. Ahimastos AA, Pappas EP, Buttner PG, et al. Ameta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication. J Vasc Surg. 2011;54(5): 1511-1521.
14. Gardner AW, Skinner JS, Cantwell BW, Smith LK. Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc. 1991;23(4):402-408.
15. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31(1): 103-115.
16. Treasure T, MacRae KD.Minimisation: The platinum standard for trials? BMJ. 1998;317(7155): 362-363.
17. JongertMWAHH, van Hoek J, Klaasboer-Kogelman K, et al. KNGF-richtlijn claudicatio intermittens [in Dutch]. Ned Tijdschr Fysioth. 2003;6:1-50.
18. Lauret GJ, Gijsbers HJ, Hendriks EJ, et al. The ClaudicatioNet concept: design of a national integrated care network providing active and healthy aging for patients with intermittent claudication. Vasc Health Risk Manag. 2012;8:495-503.
19. Froberg DG, Kane RL.Methodology for measuring health-state preferences, II: scaling methods. J Clin Epidemiol. 1989;42(5):459-471.
20. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30 (6):473-483.
21. Bosch JL, van der Graaf Y, Hunink MG, et al. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease. Circulation. 1999;99(24):3155-3160.
22. Morgan MB, Crayford T, Murrin B, Fraser SC. Developing the Vascular Quality of Life Questionnaire: A new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg. 2001;33(4):679-687.
23. Greenhalgh RM, Belch JJ, Brown LC, et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy. Eur J Vasc Endovasc Surg. 2008;36(6):680-688.
24. Spronk S, Bosch JL, den Hoed PT, et al. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training-randomized controlled trial. Radiology. 2009;250(2):586-595.
25. Bendermacher BL,Willigendael EM, Teijink JA, Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2006; (2):CD005263.
26. Clark TG, Altman DG, De Stavola BL. Quantification of the completeness of follow-up. Lancet. 2002;359(9314):1309-1310.
27. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley & Sons; 1987.
28. Tobin J. Estimation of relationships for limited dependent variables. Econometrica. 1958;26(1):24-36.
29. Frans FA, Nieuwkerk PT, Met R, et al. Statistical or clinical improvement? determining theminimally important difference for the vascular quality of life questionnaire in patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2014;47(2):180-186.
30. Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease. Circulation. 2012;125(1):130-139.
31. Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: The CLEVER study. J Am Coll Cardiol. 2015;65(10):999-1009.
32. Mazari FA, Khan JA, Carradice D, et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. Br J Surg. 2012;99(1):39-48.
33. Reynolds MR, Apruzzese P, Galper BZ, et al. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication. J Am Heart Assoc. 2014;3(6):e001233.
34. Mazari FA, Khan JA, Carradice D, et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. Br J Surg. 2013;100(9):1172-1179.
35. Spronk S, Bosch JL, den Hoed PT, et al. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: A randomized controlled trial. J Vasc Surg. 2008;48(6):1472-1480.
36. Gardner AW, Parker DE, Montgomery PS, et al. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: A randomized controlled trial. Circulation. 2011;123(5):491-498.
37. McDermott MM, Guralnik JM, Criqui MH, et al. Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation. 2014;130(1):61-68.
38. Hiatt WR,Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Circulation. 1994;90(4):1866-1874.
39. Gardner AW, Montgomery PS, Parker DE. Optimal exercise program length for patients with claudication. J Vasc Surg. 2012;55(5):1346-1354.